Abstract
Scar formation and resultant contracture can be considered the body’s response to an untoward event. Dupuytren’s contractures and burn scar contractures share significant similarities. The purpose of this presentation is to review the intersection of burn scar and Dupuytren’s contractures. The goal of this treatise is to question these two boxes from a different perspective from within and from outside as to their overlap and apply that knowledge to further better treatment of both.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Qattan MM (2006) Factors in the pathogenesis of Dupuytren’s contracture. J Hand Surg Am 31(9):1527–1534
Bayat A, Watson JS, Stanley JK, Alansari A, Shah M, Ferguson MWJ, Ollier WER (2002) Genetic susceptibility in Dupuytren’s disease – TGF-beta 1 polymorphisms and Dupuytren’s disease. J Bone Joint Surg Br 84(2):211–215
Branski LK, Gauglitz GG, Herndon DN, Jeschke MG (2009) A review of gene and stem cell therapy in cutaneous wound healing. Burns 35(2):171–180
Cordova A, Tripoli M, Corradino B, Napoli P, Moschella F (2005) Dupuytren’s contracture: an update of biomolecular aspects and therapeutic perspectives. J Hand Surg Br 30:557–562
Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J (1983) Hypertrophic burn scars: analysis of variables. J Trauma 23(10):895–898
Derderian CA, Bastidas N, Lerman OZ, Bhatt KA, Lin S, Voss J, Holmes JW, Levine JP, Gurtner GC (2005) Mechanical strain alters gene expression in an in vitro model of hypertrophic scarring. Ann Plas Surg 55(1):69–75
Duncan JAL, Bond JS, Mason T, Ludlow A, Cridland P, O’Kane S, Ferguson MWJ (2006) Visual analogue scale scoring and ranking: a suitable and sensitive method for assessing scar quality? Plast Reconstr Surg 118(4):909–918
Dunkin CSJ, Pleat JM, Gillespie PH, Tyler MPH, Roberts AHN, McGrouther DA (2007) Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 119(6):1722–1732
Dupuytren G (1832) Lecons orales de clinique chirurgicale faites a l’Hotel-dieu de Paris. Bailliere, Paris, 1: pp 413–516. In: Burns of the upper extremity, salisbury and pruitt, Vol. XIX. In: Major problems of clinical surgery. W.B. Saunders, Philadelphia, 1976 and in Total burn care, 2nd edition. Herndon (ed) Saunders, London, 2002
Ferguson MWJ, O’Kane S (2004) Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 359(1445):839–850
Gabbiani G, Majno G (1972) Dupuytren’s contracture: fibroblast connection? an ultrastructional study. Am J Pathol 66:131–146
Greenhalgh DG (2005) Models of wound healing. J Burn Care Rehabil 26(4):293–305
Hueston JT (1974) Aetological questions in Dupuytren’s contracture. In: Hueston JT, Tubiana R (eds) Dupuytren’s Disease. Grune & Stratton, New York, pp 29–36
Iselin M (1974) Mysterious aspects of Dupuytren’s Contracture. In: Hueston JT, Tubiana R (eds) Dupuytren’s Disease. Grune & Stratton, New York, pp 67–70
Junker JPE, Kratz C, Tollbäck A, Kratz G (2008) Mechanical tension stimulates the transdifferentiation of fibroblasts into myofibroblasts in human burn scars. Burns 34(7):942–946
Kraljevic Pavelic S, Bratulic S, Hock K, Jurisic D, Hranjec M, Karminski-Zamola G, Zinic B, Bujak M, Pavelic K (2009) Screening of potential prodrugs on cells derived from Dupuytren’s disease patients. Biomed Pharmacother 63(8):577–585
Kuhn M, Wang X, Payne W, Ko F, Robson M (2002) Tamoxifen decreases fibroblast function and down regulates TGFB2 in Dupuytren’s affected palmar fascia. J Surg Res 103:146–152
Kwan P, Hori K, Ding J, Tredget E (2009) Scar and contracture: biological principles. Hand Clin 25:511–528
Larson DL, Abston S, Evans EB, Dobrokovsky M, Linares HA (1971) Techniques for decreasing scar formation and contractures in the burned patient. J Trauma 1(10):807–823
Leclère FM, Mordon SR (2010) Twenty-five years of active laser prevention of scars: what have we learned? J Cosmet Laser Ther 12(5):227–34
Lermusiaux JL, Debeyre N (1979) Le traitment medical de la maladie de Dupuytren. In: de Seze S, Ryckewaert A, Kahn MF, Kuntz D, Dryll A, Meyer O et al (eds) L’actualite rhumatologique. Expansion Scientifique, Paris, pp 3383–3443
Linares HA (2002) Pathophysiology of the burn scar. In: Herndon DN (ed.) Total burn care, 2nd edition, Chap. 44. Saunders, London, pp 544–559
Morris DE, Wu LL, Zhao L, Bolton L, Roth SI, Ladin D, Mustoe TA (1997) Acute and chronic animal models for excessive dermal scarring: Quantitative studies. Plast Reconstr Surg 100(3):674–681
Mustoe TA, Cooter RD, Gold MH, Hobbs R, Ramelet A-A, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler U (2002) International clinical recommendations on scar management for the International Advisory Panel on Scar Management. Plast Reconstr Surg 110:560
Nekouzadeh A, Pryse KM, Elson EL, Genin GM (2008) Stretch-activated force-shedding, force recovery, and cytoskeletal remodeling in contractile fibroblasts. J Biomech 41(14):2964–2971
Perkins K, Davey RB, Wallis KA (1983) Silicone Gel: a new treatment for burn scars and contractures. Burns 9(3):201–204
Pittet B, Rubbia-Brandt L et al (1994) Effect of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren’s disease: an open pilot study. Plast Recontsr Surg 93(6):1224–1235
Polo M, Ko F, Busillo B, Cruse C, Krizek T, Robson M (1997) The 1997 Moyer Award: cytokine production in burn patients with hypertrophic scars. J Burn Care Rehabil 18:477–483
Polo M, Kim Y, Kucukcelebi A, Hayward PG, Ko F, Robson MC (1998) An in vivo model of human proliferative scar. J Surg Res 74:187–195
Rayan GM, Parizi M, Tomasek JJ (1996) Pharmacologic regulation of Dupuytren’s fibroblasts contraction in vitro. J Hand Surg Am 21:1065–1070
Robb EC, Waymack JP, Warden GD, Nathan P, Alexander JW (1987) A new model for studying the development of human hypertrophic burn scar formation. J Burn Care Rehabil 8(5):371–375
Robson MC (2003) Proliferative scarring. Surg Clin North Am 83:557–569
Sahara K, Kucukcelebi A, Ko F, Phillips L, Robson M (1993) Suppression of in vitro proliferative scar fibroblast contraction by interferon alpha-2â. Wound Repair Regen 1:22–27
Sandford S (1995) Apples and Oranges — a comparison. AIR 1(3)
Scott PG, Gharary A, Tredget EE (2000) Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16(2):27
Scott PG, Ghahary A, Tredget EE (2002) Molecular and cellular basis of hypertrophic scarring. In: D. Herndon (ed). Total burn care, 2nd edition, Chapt. 43. Saunders, London, pp 536–543
Shih B, May T, Watson J, McGrouther D, Bayat A (2010) Genome-Wide High-Resolution Screening in Dupuytren’s Disease Reveals Common Regions of DNA Copy Number Alterations. J Hand Surg Am 35A:1172–1183
Singer AJ, Clark RAF (1999) Cutaneous wound healing. N Engl J Med 341(10):738–746
Tomasek JU, Gabbiani G, Hinz B, Chaponnier C, Ra B (2002) Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 3:349–363
Wang J, Dodd C, Shankowsky HA, Scott PG, Tredget EE (2008) Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88:1278–1290
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zidel, P. (2012). Dupuytren’s Contracture Versus Burn Scar Contracture. In: Eaton, C., Seegenschmiedt, M., Bayat, A., Gabbiani, G., Werker, P., Wach, W. (eds) Dupuytren’s Disease and Related Hyperproliferative Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22697-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-22697-7_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-22696-0
Online ISBN: 978-3-642-22697-7
eBook Packages: MedicineMedicine (R0)